The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

Clinical trial NCT07200596 · COMPLETED

Trial details

NCT number: NCT07200596
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)

Start date: 2025-10-08
Primary completion: 2026-03-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.